ClinicalTrials.gg
CompletedNCT01894282Updated Mar 31, 2022

Mind Body Intervention for Chronic Lower Back Pain

A Phase 3 interventional study of Manual Therapy and Mind Body Intervention in Chronic Lower Back Pain, sponsored by Canandaigua VA Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 69 Years. Per ClinicalTrials.gov, last updated 2022-03-31.

Sponsored by Canandaigua VA Medical Center · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
4
Allocation
Randomized
Ages
18 Years to 69 Years
Sex
All
01

Study summary

This pilot study will evaluate the feasibility of having a non-behavioral health provider deliver a combination of manual therapy (MT) and cognitive behavioral therapy for pain (CBT-p). In addition, we will evaluate differences in outcomes in patients undergoing the combined intervention of CBT-p and MT and those undergoing MT alone.

Read the detailed description

Given that this is a pilot study we will use simple descriptive statistics for patient characteristics, including age, sex, BMI and baseline scores on outcome measures. In addition we will assess the inter-rater reliability of the scoring of the delivery of the CBT-p by the two trained practitioners utilizing kappa statistics. We will perform data analyses using SPSS.

02

Conditions studied

  • Chronic Lower Back Pain

Browse trials for

Keywords

  • Chronic Lower Back Pain
  • Manual Therapy
  • Cognitive Behavioral Therapy
03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's enrollment of 4 is below the median of 60 across 2,364 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Canandaigua VA Medical Center is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 69 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 to 69 years of age with CLBP who are
  • "high risk" for poor prognosis based on SBST
  • currently undergoing chiropractic care.

Exclusion criteria

Exclusion Criteria:

  • to either MT or CBT-p.
  • Patients who are currently undergoing CBT-p
  • who have been treated for substance abuse in the past year.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
4 participants (actual)

Study arms

  • Active comparator
    Manual Therapy

    Spinal Manipulative therapy (SMT) for the purpose of this study we will allow the use of other types of MT, including non-thrust spinal mobilization and flexion-distraction technique.

    Procedure: Manual Therapy

  • Experimental
    Mind Body Intervention (MBI)

    Mind Body Intervention will consist of a combination of the previously described "manual therapy" and Cognitive Behavioral Therapy for pain (CBT-p). Cognitive Behavioral Therapy for pain management has three basic components. The treatment rationale, coping skills training and application and maintenance of learned coping skills.

    Procedure: Manual Therapy · Procedure: Mind Body Intervention

Interventions

  • ProcedureManual Therapy

    Manual Therapy Arm

    Also known as: Spinal Manipulative Therapy, Spinal Mobilization, Flexion Distraction Therapy

  • ProcedureMind Body Intervention

    Combination of manual therapy and cognitive behavioral therapy for pain.

    Also known as: Manual Therapy, Cognitive Behavioral Therapy for Pain

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale

    The VAS is a patient completed analogue measure that evaluates pain intensity on a 100 mm long horizontal line, which is anchored at each end with a statement representing the extremes of the dimension being measured. In this case the left hand side reads, "no pain" and the right hand side reads "worst pain possible". The VAS scale utilized will assess pain at the current time. The VAS has been established as a reliable, valid and generalizable measure that can be administered in a wide range of clinical and experimental settings.

    Time frame: Baseline and 6 weeks post baseline (immediately post intervention)

Secondary outcomes

  1. PROMIS Global Health Scale (GHS)

    Health outcomes assessment has advanced to a point where generic health-related quality of life (HRQL) measures are often used to examine the health status of populations and the effects of medical interventions. Generic HRQL profile measures, such as the SF-36 Health Survey, provide multiple health domains scores (e.g., physical function, mental health, pain, vitality, etc.), but not an overall index score. Patient reported outcome measurement information system has developed a quality of life tool that provides an overall index score for quality of life. The main advantage of the PROMIS measures over other static health status measures is that the PROMIS domain item banks and scores allow flexibility in administration using either targeted short forms or computerized adaptive testing. This form has recently been validated in comparison to the EuroQual.

    Time frame: Baseline and 6 weeks post baseline (immediately post intervention)

Other outcomes

  1. Patient Satisfaction Questionnaire

    Cherkin et al, in the evaluation of a physician education program developed a patient satisfaction questionnaire which was found to be reliable and valid. The questionnaire utilized in this study will incorporate these same questions. Additional questions to be included focus on the burden of the data collection activities, and suggestions for subject recruitment.

    Time frame: Baseline and post intervention

07

Study locations

1 site
  • Rochester Outpatient Clinic
    Rochester, New York 14620, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2013, a primary completion of Aug 2017 and a completion of Nov 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2013
First posted
Jul 10, 2013
Start
Jul 2013
Primary completionActual
Aug 2017
CompletionActual
Nov 2017
Last update
Mar 31, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 31, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01894282
Lead sponsor
Canandaigua VA Medical Center
Responsible party
Paul Dougherty, DC (Chiropractor, Canandaigua VA Medical Center) — Principal investigator
First posted
Jul 10, 2013
Start date
Jul 2013
Primary completion
Aug 2017
Completion
Nov 2017
Last update
Mar 31, 2022

Study contacts

Paul Dougherty, DC
principal investigator · Canandaigua VA Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion